Crombie heads Virax
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Monday, 19 May, 2014 - 13:00
Category:
Biotech company Virax Holdings has appointed Rob Crombie as managing director, from mid-June.
Dr Crombie is a scientist with senior management experience at Arana Therapeutics and EvoGenix.
He is currently a consultant providing specialist advice to start-up innovation companies.
Virax is developing immunotherapies that boost the immune system to treat a broad range of diseases.
Companies:
People: